Novel TPP-riboswitch activators bypass metabolic enzyme dependency

Christina E. Lünse, Fraser J. Scott, Colin J. Suckling, Günter Mayer

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Riboswitches are conserved regions within mRNA molecules that bind specific metabolites and regulate gene expression. TPP-riboswitches, which respond to thiamine pyrophosphate (TPP), are involved in the regulation of thiamine metabolism in numerous bacteria. As these regulatory RNAs are often modulating essential biosynthesis pathways they have become increasingly interesting as promising antibacterial targets. Here, we describe thiamine analogs containing a central 1,2,3-triazole group to induce repression of thiM-riboswitch dependent gene expression in different E. coli strains. Additionally, we show that compound activation is dependent on proteins involved in the metabolic pathways of thiamine uptake and synthesis. The most promising molecule, triazolethiamine (TT), shows concentration dependent reporter gene repression that is dependent on the presence of thiamine kinase ThiK, whereas the effect of pyrithiamine (PT), a known TPP-riboswitch modulator, is ThiK independent. We further show that this dependence can be bypassed by triazolethiamine-derivatives that bear phosphate-mimicking moieties. As triazolethiamine reveals superior activity compared to pyrithiamine, it represents a very promising starting point for developing novel antibacterial compounds that target TPP-riboswitches. Riboswitch-targeting compounds engage diverse endogenous mechanisms to attain in vivo activity. These findings are of importance for the understanding of compounds that require metabolic activation to achieve effective riboswitch modulation and they enable the design of novel compound generations that are independent of endogenous activation mechanisms.
Original languageEnglish
Number of pages8
JournalFrontiers in Chemistry
Volume2
DOIs
Publication statusPublished - 28 Jul 2014
Externally publishedYes

Fingerprint

Riboswitch
Thiamine Pyrophosphate
Enzymes
Thiamine
Pyrithiamine
Chemical activation
Gene expression
Molecules
Triazoles
Biosynthesis
Metabolites
Metabolism
Escherichia coli
Modulators
Bacteria
Genes
Phosphates
Modulation
RNA
Derivatives

Cite this

Lünse, Christina E. ; Scott, Fraser J. ; Suckling, Colin J. ; Mayer, Günter. / Novel TPP-riboswitch activators bypass metabolic enzyme dependency. In: Frontiers in Chemistry. 2014 ; Vol. 2.
@article{368954fc9c8a49aab8cfd2636eb93adc,
title = "Novel TPP-riboswitch activators bypass metabolic enzyme dependency",
abstract = "Riboswitches are conserved regions within mRNA molecules that bind specific metabolites and regulate gene expression. TPP-riboswitches, which respond to thiamine pyrophosphate (TPP), are involved in the regulation of thiamine metabolism in numerous bacteria. As these regulatory RNAs are often modulating essential biosynthesis pathways they have become increasingly interesting as promising antibacterial targets. Here, we describe thiamine analogs containing a central 1,2,3-triazole group to induce repression of thiM-riboswitch dependent gene expression in different E. coli strains. Additionally, we show that compound activation is dependent on proteins involved in the metabolic pathways of thiamine uptake and synthesis. The most promising molecule, triazolethiamine (TT), shows concentration dependent reporter gene repression that is dependent on the presence of thiamine kinase ThiK, whereas the effect of pyrithiamine (PT), a known TPP-riboswitch modulator, is ThiK independent. We further show that this dependence can be bypassed by triazolethiamine-derivatives that bear phosphate-mimicking moieties. As triazolethiamine reveals superior activity compared to pyrithiamine, it represents a very promising starting point for developing novel antibacterial compounds that target TPP-riboswitches. Riboswitch-targeting compounds engage diverse endogenous mechanisms to attain in vivo activity. These findings are of importance for the understanding of compounds that require metabolic activation to achieve effective riboswitch modulation and they enable the design of novel compound generations that are independent of endogenous activation mechanisms.",
keywords = "Riboswitches, triazolethiamine, click-chemistry, metal-chelating compounds, metabolic enzymes",
author = "L{\"u}nse, {Christina E.} and Scott, {Fraser J.} and Suckling, {Colin J.} and G{\"u}nter Mayer",
year = "2014",
month = "7",
day = "28",
doi = "10.3389/fchem.2014.00053",
language = "English",
volume = "2",
journal = "Frontiers in Chemistry",
issn = "2296-2646",
publisher = "Frontiers Media S.A.",

}

Novel TPP-riboswitch activators bypass metabolic enzyme dependency. / Lünse, Christina E.; Scott, Fraser J.; Suckling, Colin J.; Mayer, Günter.

In: Frontiers in Chemistry, Vol. 2, 28.07.2014.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Novel TPP-riboswitch activators bypass metabolic enzyme dependency

AU - Lünse, Christina E.

AU - Scott, Fraser J.

AU - Suckling, Colin J.

AU - Mayer, Günter

PY - 2014/7/28

Y1 - 2014/7/28

N2 - Riboswitches are conserved regions within mRNA molecules that bind specific metabolites and regulate gene expression. TPP-riboswitches, which respond to thiamine pyrophosphate (TPP), are involved in the regulation of thiamine metabolism in numerous bacteria. As these regulatory RNAs are often modulating essential biosynthesis pathways they have become increasingly interesting as promising antibacterial targets. Here, we describe thiamine analogs containing a central 1,2,3-triazole group to induce repression of thiM-riboswitch dependent gene expression in different E. coli strains. Additionally, we show that compound activation is dependent on proteins involved in the metabolic pathways of thiamine uptake and synthesis. The most promising molecule, triazolethiamine (TT), shows concentration dependent reporter gene repression that is dependent on the presence of thiamine kinase ThiK, whereas the effect of pyrithiamine (PT), a known TPP-riboswitch modulator, is ThiK independent. We further show that this dependence can be bypassed by triazolethiamine-derivatives that bear phosphate-mimicking moieties. As triazolethiamine reveals superior activity compared to pyrithiamine, it represents a very promising starting point for developing novel antibacterial compounds that target TPP-riboswitches. Riboswitch-targeting compounds engage diverse endogenous mechanisms to attain in vivo activity. These findings are of importance for the understanding of compounds that require metabolic activation to achieve effective riboswitch modulation and they enable the design of novel compound generations that are independent of endogenous activation mechanisms.

AB - Riboswitches are conserved regions within mRNA molecules that bind specific metabolites and regulate gene expression. TPP-riboswitches, which respond to thiamine pyrophosphate (TPP), are involved in the regulation of thiamine metabolism in numerous bacteria. As these regulatory RNAs are often modulating essential biosynthesis pathways they have become increasingly interesting as promising antibacterial targets. Here, we describe thiamine analogs containing a central 1,2,3-triazole group to induce repression of thiM-riboswitch dependent gene expression in different E. coli strains. Additionally, we show that compound activation is dependent on proteins involved in the metabolic pathways of thiamine uptake and synthesis. The most promising molecule, triazolethiamine (TT), shows concentration dependent reporter gene repression that is dependent on the presence of thiamine kinase ThiK, whereas the effect of pyrithiamine (PT), a known TPP-riboswitch modulator, is ThiK independent. We further show that this dependence can be bypassed by triazolethiamine-derivatives that bear phosphate-mimicking moieties. As triazolethiamine reveals superior activity compared to pyrithiamine, it represents a very promising starting point for developing novel antibacterial compounds that target TPP-riboswitches. Riboswitch-targeting compounds engage diverse endogenous mechanisms to attain in vivo activity. These findings are of importance for the understanding of compounds that require metabolic activation to achieve effective riboswitch modulation and they enable the design of novel compound generations that are independent of endogenous activation mechanisms.

KW - Riboswitches

KW - triazolethiamine

KW - click-chemistry

KW - metal-chelating compounds

KW - metabolic enzymes

U2 - 10.3389/fchem.2014.00053

DO - 10.3389/fchem.2014.00053

M3 - Article

VL - 2

JO - Frontiers in Chemistry

JF - Frontiers in Chemistry

SN - 2296-2646

ER -